English German Spanish

News

Press release Fluido test equipment

Amersfoort, April 26, 2011.

With the Fluido® AirGuard System and the Fluido® blood and fluid warmer being sold in Europe, Middle East, Africa and Asia Pacific the demand for an easy to handle and accurate test equipment increased.

TSCI is proud to announce that we have released the second generation of the Fluido® tester, developed and manufactured in Amersfoort. The Fluido® tester is developed for testing flow and temperature of the Fluido® blood and fluid warmer and the Fluido® Irrigation fluid warmer.

The second generation Fluido® tester is working with standard cassettes and contains a data logging software and hardware. This will allow the biomedical engineers to do a quick and accurate service check of the Fluido®.

“With the development of this second generation Fluido® tester we have implemented the feedback from the field” states Ron van Oudenallen, R&D engineer at TSCI.

About TSCI B.V.,
TSCI has been an expert in the field of hypothermia for more than 25 years. A true partner with dedication; by organising hands-on training sessions and workshops. The development of the Mistral-Air® Forced Air Warming, and the Fluido® Blood and Fluid Warming lines was initiated by, and designed together with users in the medical field to fill an existing need. In combination with the Thermoflect® product line, TSCI is offering a complete package for Patient Temperature Management.

TSCI is a member of The Surgical Company Group, headquarters in The Netherlands.
 

The Surgical Company Group in Europe's TOP 500

 

The Surgical Company Group was ranked place 70 on the nomination list of the TOP 500 fastest growing companies in Europe. The celebration event was hosted in the European Parliament in Brussels on February 4th, 2011.

On the picture Gerhard Schroeder, former Chancellor of Germany, handed over the TOP 500 certificate to Luc Van Schil, CEO of The Surgical Company Group.

This award recognises the rapid growth in sales and creation of jobs by the TSC-Group.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mistral-Air receives 510(k) clearance

 

07-2010 Mistral-Air receives 510(k) clearance

The Mistral-Air Plus Forced Air Warming Unit has received a 510(k) clearance of the FDA U.S. Food and Drug administration.

Introduction
Section 510(k) of the Food, Drug and Cosmetic Act requires device manufacturers who must register, to notify FDA of their intent to market a medical device at least 90 days in advance.
Read more about 510(k) clearance
 

Download certificate